Attached files

file filename
8-K - FORM 8-K - KRANEM CORPform8k.htm
EX-99.1 - EXHIBIT 99.1 - KRANEM CORPexhibit99-1.htm

Exhibit 10.1

Confidential Treatment Requested. Confidential portions of this document have
been redacted and have been separately filed with the SEC.

SPA

STOCK PURCHASE AGREEMENT

THIS Restricted Stock Purchase Agreement (the “Agreement”), made on November 30, 2011(the “Effective Date”), is by and between, Alessandro D’Alesio (“Mr. D’ Alesio,” who is the Chief Executive Officer (Amministratore Unico) of the Company), an individual, Alfa Sistemi Telemedia Srl, an Italian corporation (the “Company”), Maria Fausto Greco (“Ms. Greco”), an individual, who owns 99% of the Company, Aldo Greco (“Mr. Greco,” collectively with Ms. Greco, the “Sellers”), an individual, who owns 1 % of the Company (and Kranem Corporation, a Colorado corporation (the “Purchaser”). Mr. D’Alesio, Ms. Greco, Mr. Greco, the Company and the Purchaser are hereinafter sometimes referred to collectively as the “Parties” and individually as a “Party.”

WHEREAS, the Purchaser wishes to purchase from the Sellers all of the Purchaser’s shares of the of the Company (the “Company Shares”) under the terms and conditions of this Agreement;

WHEREAS, the Sellers desire to sell to the Purchaser the Company Shares under the terms and conditions of this Agreement; and

WHEREAS, the Company consents to the sale of the Company Shares by the Sellers to the Purchaser under the terms and conditions of this Agreement.

NOW, THEREFORE, in consideration of the mutual promises contained herein and other good and valuable consideration, receipt of which is hereby acknowledged, the Parties to this Agreement agree as follows:

1. Sale of the Shares.

(a) Sale of the Shares. The Sellers agree to sell to the Purchaser and the Purchaser agrees to purchase the Company Shares for a total price ***** (the “Purchase Price”), part of which shall be paid in cash and part of which shall be paid in the common stock of the Purchaser (the “Common Stock”) as follows: (a) ***** in cash (the “Cash Consideration”), which shall be wired to the bank account specified by the Sellers on the later of (i) six months of the Effective Date or (ii) the date of the Company’s next financing (the “Next Financing”); and (b) ***** shares of the common stock (the “Common Stock”) of the Purchaser (the “Stock Consideration” or the “Purchaser Shares”), which is worth approximately ***** at the current market price of $1.0 per share and shall be issued to the Sellers at the Closing.

(b) Closing; Delivery. The closing of this Agreement shall take place on the Effective Date at the Purchaser’s offices at 10:00 a.m., California standard time, or at such other time and place as the Sellers, the Company and the Purchaser mutually agree (the “Closing”). At the Closing, the Sellers shall deliver or cause the Company to deliver to the Purchaser the stock certificate for the Company Shares in the name of the Sellers. The Purchaser shall deliver or cause its transfer agent to deliver to the Sellers the stock certificate in the name of the Sellers as soon as possible after the Closing.

1 of 8


Confidential Treatment Requested. Confidential portions of this document have
been redacted and have been separately filed with the SEC.

SPA

(c) Restricted Securities. The Sellers hereby confirm that they have been informed that the Purchaser Shares are “restricted securities” under the Securities Act of 1933, as amended (the “1933 Act”). The Sellers, jointly and severally, acknowledge that the Purchaser Shares may not be resold or transferred unless the Purchaser Shares are first registered under the federal securities laws or unless an exemption from such registration is available. Each Seller hereby acknowledges that he/she is prepared to hold the Purchaser Shares for an indefinite period. Each Seller acknowledges that he/she is aware that Rule 144 of the Securities and Exchange Commission issued under the 1933 Act is not presently available to exempt the sale of the Purchaser Shares from the registration requirements of the 1933 Act. The Parties acknowledge that the requirements of Rule 144 are subject to change at any time.

(d) Disposition of the Shares. Subject to the terms of this Agreement, each Seller hereby agrees that he/she shall transfer, sell or otherwise dispose of the Purchaser Shares in accordance with Rule 144. The Purchaser shall not be required to transfer on its books any Purchaser Shares, which have been sold or transferred in violation of the provisions of this Agreement. The Purchaser shall not be required to treat any transferee to whom the Purchaser Shares have been transferred in contravention of this Agreement as the owner of the Purchaser Shares.

(f) Transfer Restrictions.

(i) Definition of Owner. For purposes of this Agreement, the term “Owner” shall include each Seller and all subsequent holders of the Purchaser Shares, who derive their ownership through a permitted transfer from each Seller in accordance with subsection 1(f)(ii) below.

(ii) Restriction on Transfer. The Owner shall not transfer, assign, encumber or otherwise dispose of any of the Purchaser Shares without the prior written consent of the Purchaser.

(iii) Obligations of Transferee. Each person to whom the Purchaser Shares are transferred by means of one of the permitted transfers must, as a condition precedent to the validity of such transfer, acknowledge in writing to the Purchaser that such person is bound by the provisions of this Agreement.

(g) Company Consent. The Company hereby consents to the sale of the Company Shares by the Sellers to the Purchaser and agrees to take whatever steps and file or issue whatever documents necessary to effectuate the sale of the Company Shares and the intent of this Agreement.

(h) Employment and Non-compete. As additional consideration for the Purchaser to purchase the Company Shares from the Sellers and issue the Purchaser Shares to the Sellers, the Sellers and Mr. D’Alesio hereby covenant to the Purchaser that Mr. D’Alesio, to the greatest extent allowed under applicable law, will (i) continue to work for the Company as the Chief Executive Officer (Amministratore Unico) at an annual salary of ***** (which salary shall be reviewed annually by the Board), for five years from the Effective Date provided the Company does not significantly change his responsibilities or his compensation; and (ii) not work for a competitor of the Company nor compete with the Company for two years after his termination by the Company.

2 of 9


Confidential Treatment Requested. Confidential portions of this document have
been redacted and have been separately filed with the SEC.

SPA

(i) *************************************************.

(j) Breakup Fee. The Purchaser agrees to pay to the Sellers ***** (split by the percent ownership of Ms. Greco and Mr. Greco) a breakup fee if the transaction does not close at the later of (i) six months of the Effective Date or (ii) the closing of the Next Financing, provided that the closing is not delayed or prevented by the acts of Ms. Greco, Mr. Greco, Mr. D’Alesio, or the Company.

2. Representations and Warranties of the Company and the Sellers. The Company and each Seller, jointly and severally, hereby represents and warrants to the Purchaser that:

(a) Organization, Good Standing and Qualification. The Company is a corporation duly organized, validly existing and in good standing under the laws of Italy and has all requisite corporate power and authority to carry on its business as now conducted and as proposed to be conducted.

(b) Authorization. All corporate action on the part of the Company, its officers, directors and shareholders necessary for the authorization, execution and delivery of this Agreement and the authorization, sale, issuance and delivery of the Company Shares and the performance of all obligations of the Company hereunder has been taken or will be taken prior to the Closing.

(c) Valid Obligations. The Agreement, when executed and delivered by the Sellers, Mr. Alesio and the Company, shall constitute valid and legally binding obligations of the Sellers and the Company, enforceable against the Sellers and the Company in accordance with their terms.

(d) Outstanding Company Shares. The Company Shares constitute all of the outstanding stock of the Company and there are no shareholders of the Company other than the Sellers.

(e) Capital Stock. All the outstanding capital stock of the Company, including the Company Shares, is validly issued, fully paid and nonassessable. All outstanding the Company capital stock has been issued in full compliance with applicable law.

(f) Intellectual Property. The Company exclusively owns all right, title and interest to and in the Company’s intellectual property described to the Purchaser during discussions in connection with this Agreement free and clear of any Encumbrances.

3 of 9


Confidential Treatment Requested. Confidential portions of this document have
been redacted and have been separately filed with the SEC.

SPA

(g) Assets. The Sellers own, and has good and valid title to, all of the assets set forth in the Company’s financial statements, given to the Purchaser during discussions in connection with this Agreement, free and clear of any encumbrances.

(h) Articles of Incorporation. The Company and the Sellers have delivered to the Purchaser accurate and complete current copies of the Company’s articles of incorporation and bylaws.

(i) Financial Statements. The Company and the Sellers have delivered to the Purchaser accurate and complete current copies of the Company’s financial statements, which shall cover the period through the end of the second quarter of 2011 (“Financial Statements”).

(j) Legal Requirements. The Company is in full compliance with each legal requirement that is applicable to it or to the conduct of its business or the ownership or use of any of its assets and the Company has at all times been in full compliance with each legal requirement that is or was applicable to it or to the conduct of its business or the ownership or use of any of its assets.

(k) Full Disclosure. This Agreement does not contain any untrue statement of fact and does not omit to state any fact necessary to make any of the representations, warranties or other statements or information contained therein not misleading. All of the information regarding the Company and its business, condition, assets, liabilities, operations, financial performance, net income and prospects that has been furnished to the Purchaser or any of the Purchaser’s Representatives by or on behalf of the Sellers or the Company is accurate and complete in all respects. Each Seller agrees and acknowledges that, if a liability or debt owed by the Company on the Effective Date has not been previously identified in writing in the Financial Statements given to the Purchaser on or before the Effective Date will be transferred to and become the liability and debt of the Sellers and shall not be a liability or debt of the Company or the Purchaser.

3. Representations and Warranties of the Sellers. Each Seller hereby severally represents and warrants to the Purchaser that:

(a) Purchase Entirely for Own Account. The Purchaser Shares (“Securities”) to be acquired by each of the Sellers will be acquired for investment for the Seller’s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and each of the Sellers has no present intention of selling, granting any participation in, or otherwise distributing the same.

(b) Knowledge. Each Seller is aware of the Purchaser’s business affairs and financial condition and has acquired sufficient information about the Purchaser to make an informed and knowledgeable decision to acquire the Securities.

(c) Restricted Securities. Each Seller understands that the Securities are “restricted securities” under applicable U.S. federal and state securities laws. Each Seller acknowledges that the Company has no obligation to register or qualify the Securities for resale.

4 of 9


Confidential Treatment Requested. Confidential portions of this document have
been redacted and have been separately filed with the SEC.

SPA

(d) Accredited Investor. Each Seller is an “Accredited Investor” as defined in Rule 501(a) of Regulation D promulgated under the Act.

4. Representations and Warranties of the Purchaser. The Purchaser hereby represents and Warrant to each Seller that

(a) Organization, Good Standing and Qualification. The Purchaser is a corporation duly organized, validly existing and in good standing under the laws of California and has all requisite corporate power and authority to carry on its business as now conducted and as proposed to be conducted.

(b) Authorization. All corporate action on the part of the Purchaser, its officers, directors and shareholders necessary for the authorization, execution and delivery of this Agreement and the authorization, sale, issuance and delivery of the Purchaser Shares and the performance of all obligations of the Purchaser hereunder has been taken or will be taken prior to the Closing.

(c) Valid Obligations. The Agreement, when executed and delivered by the Purchaser, shall constitute valid and legally binding obligations of the Purchaser, enforceable against the Purchaser in accordance with their terms.

(d) Capital Stock. All of the outstanding capital stock of the Purchaser is, and upon issuance of the Purchaser Shares pursuant to this Agreement, all of the Purchaser Shares will be, validly issued, fully paid and nonassessable. All outstanding the Purchaser’s capital stock has been issued in full compliance with applicable law.

5. Conditions of the Purchaser’s Obligations at Closing. The obligations of the Purchaser to each Seller under this Agreement are subject to the fulfillment, on or before the Closing, of the following conditions, unless otherwise waived:

(a) Representations and Warranties. The representations and warranties of each Seller and the Company contained in Sections 2 and 3 shall be true on and as of the Closing with the same effect as though such representations and warranties had been made on and as of the date of the Closing.

(b) Qualifications. All authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of any country or state that are required in connection with the lawful issuance and sale of the Securities pursuant to this Agreement shall be obtained and effective as of the Effective Date.

6. Conditions of the Sellers’ Obligations at Closing. The obligations of each Seller under this Agreement are subject to the fulfillment, on or before the Closing, of the following conditions, unless otherwise waived:

5 of 9


Confidential Treatment Requested. Confidential portions of this document have
been redacted and have been separately filed with the SEC.

SPA

(a) Representations and Warranties. The representations and warranties of the Purchaser contained in Section 4 shall be true on and as of the Closing with the same effect as though such representations and warranties had been made on and as of the Closing.

(b) Qualifications. All authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of country or any state that are required in connection with the lawful issuance and sale of the Securities pursuant to this Agreement shall be obtained and effective as of the Closing.

7. Miscellaneous.

(a) Successors and Assigns. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the Parties. Nothing in this Agreement, express or implied, is intended to confer upon any Party other than the Parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

(b) Governing Law; Venue. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the Parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of California, without giving effect to principles of conflicts of law. The Parties acknowledge that any action brought by a Party to interpret or enforce any provision of this Agreement shall be brought in, and the other Parties agree to and do hereby, submit to the jurisdiction and venue of, the courts of Santa Clara County in the state of California.

(c) Facsimile and Counterparts. This Agreement may be signed by facsimile and executed in two or more counterparts, each of which shall be deemed an original and all of which together shall constitute one instrument.

(d) Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.

(e) Notices. Any notice required or permitted by this Agreement shall be in writing and shall be deemed sufficient upon receipt, when delivered personally or by courier, overnight delivery service or confirmed facsimile, or forty-eight (48) hours after being deposited in the U.S. mail as certified or registered mail with postage prepaid, if such notice is addressed to the Party to be notified at such Party’s address or facsimile number is set forth in such Party’s files.

(f) Finder’s Fee. Each Party represents that it neither is nor will be obligated for any finder’s fee or commission in connection with this transaction. Each Party agrees to indemnify and to hold harmless the other Parties from any liability for any commission or compensation in the nature of a finder’s fee (and the costs and expenses of defending against such liability or asserted liability) for which such Party or any of its officers, employees, or representatives is responsible.

6 of 9


Confidential Treatment Requested. Confidential portions of this document have
been redacted and have been separately filed with the SEC.

SPA

(g) Amendments and Waivers. Any term of this Agreement may be amended or waived only with the written consent of the Company and the holders of at least a majority in interest of the Note. Any amendment or waiver affected in accordance with this Section 7(g) shall be binding upon the Purchaser and the transferee of the Securities, the future holder of all such Securities, and the Company.

(h) Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, the Parties agree to renegotiate such provision in good faith, in order to maintain the economic position enjoyed by the Party as close as possible to that under the provision rendered unenforceable. In the event that the Parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (i) such provision shall be excluded from this Agreement, (ii) the balance of the Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of the Agreement shall be enforceable in accordance with its terms.

(i) Entire Agreement. This Agreement and the documents referred to herein constitute the entire agreement between the Parties hereto pertaining to the subject matter hereof, and any and all other written or oral agreements existing between the Parties hereto are expressly canceled.

(j) Exculpation. Each Seller acknowledges that he/she is not relying upon any person, firm or corporation, other than the Purchaser and its officers and directors, in making its decision to accept the Purchaser Shares as partial consideration for his sale of the Company Shares.

(k) Sellers Remedies. In addition to any other remedy available to the Sellers at law or in equity, each Seller, at such Seller’s option, may require the Purchaser to (i) return the Company Shares to the Sellers if the Purchaser does make the Cash Contribution as set forth in Section 1(a) above; or (ii) issue an additional ***** of the Purchaser common stock at the same price as the Purchaser Shares.

(l) Purchaser Remedies. In addition to any other remedy available to the Purchaser at law or in equity, if (i) either of the Seller or the Company breaches this Agreement or (ii) the Purchaser discovers within one year of the Effective Date that the representations and warranties set forth in Sections 2 or 3 above are not true and accurate, the Purchaser, at the Purchaser’s option, may (iii) cancel this Agreement and require each Seller to refund the Cash Contribution and return the Purchaser Shares; or (iv) require each Seller to return ***** of the Cash Contribution.

(m) Waiver. No failure on the part of any Party to exercise any power, right, privilege or remedy under this Agreement, and no delay on the part of any Party in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of such power, right, privilege or remedy; and no single or partial exercise of any such power, right, privilege or remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy.

7 of 9


Confidential Treatment Requested. Confidential portions of this document have
been redacted and have been separately filed with the SEC.

SPA

(n) Further Assurances. Each Party hereto shall execute and/or cause to be delivered to each other Party hereto such instruments and other documents, and shall take such other actions, as such other Party may reasonably request for the purpose of carrying out or evidencing any of the Transactions.

[REST OF PAGE INTENTIONALLY LEFT BLANK]

 

 

8 of 9


Confidential Treatment Requested. Confidential portions of this document have
been redacted and have been separately filed with the SEC.

SPA

IN WITNESS WHEREOF, the Parties have executed this Stock Purchase Agreement as of the Effective Date.

THE PURCHASER THE SELLERS
   
Signature: /s/ Ajay Batheja                                Signature: /s/ Aldo Greco                            
Name: Ajay Batheja Name: Aldo Greco
Title: President and CEO  
  Signature: /s/ Maria Fausto Greco             
THE COMPANY Name: Maria Fausto Greco
   
Signature:/s/ Alessandro D’Alesio                  Signature: /s/ Alessandro D’Alesio           
Name: Alessandro D’Alesio Name: Alessandro D’Alesio
Title: President and CEO  

The symbol ‘*****’ in this exhibit indicates places where information has been omitted
pursuant to a request for confidential treatment and filed separately with the SEC.

9 of 9